Dr. Crowe is Director of the Vanderbilt Vaccine Center and the Ann Scott Carell Professor of Pediatrics, Pathology, Microbiology and Immunology at Vanderbilt University Medical Center. He is a board certified pediatric infectious diseases physician and viral immunology researcher. Dr. Crowe was elected to the ASCI in 2004 (profile here).
Dr. Crowe’s laboratory studies the human immune response to infection for a wide variety of major human pathogens, including many emerging infections. His research group uses a very broad array of techniques including molecular and cellular biology, state-of-the-art imaging and flow cytometry, bioinformatics, and bioengineering approaches to attack scientific problems at the forefront of immunity research.
Dr. Crowe is an elected member of the National Academy of Medicine and has been the recipient of numerous investigator awards including the 2017 ASCI Stanley J. Korsmeyer Award, the 2019 Merck Future Insight Prize, 2020 AAAS Golden Goose Award, and others. A number of vaccine candidates and human monoclonal antibodies developed in the course of his team’s research have been tested in Phase I-III clinical trials in humans.
This event was moderated by Lorraine B. Ware, MD, the ASCI’s 2021-2022 Immediate Past President. Dr. Ware is the Ralph and Lulu Owen Professor of Medicine and Director of the Vanderbilt Medical Scholars Program at Vanderbilt University School of Medicine.
Mariana J. Kaplan, MD
Casting the NET wide: Neutrophils in chronic inflammatory disorders
Mariana J. Kaplan, MD, is Senior Investigator and Chief of the Systemic Autoimmunity Branch as well as Deputy Scientific Director at the National Insti...